Who We Are

Syner-G BioPharma Group excels as a trusted development partner in the pharmaceutical industry, offering a comprehensive suite of services from drug development to regulatory filings. With a global team of more than 200 employees, Syner-G is recognized for its innovative, science-driven approach, supporting clients from pre-approval to post-approval stages.

GET STARTED

Our Mission, Vision, and Values

Mission

To enable our clients to achieve success and enhance human health through the efficient development of new therapeutic agents while inspiring our team members (everyone) to excel.

Vision

To be the trusted development partner to our clients, recognized globally for our strategic, innovative, and scientifically driven approaches to product development.

Our Values

Be Bold

We build environments where team members and clients apply innovative practices and challenge the status quo.

Be Collaborative

We cultivate relationships (synergistic and interdependent) with clients and colleagues by working collaboratively and proactively to deliver results.

Be the Best

We empower our team members to deliver work of the highest quality by setting industry best practices.

Be Benevolent

We strive to make the world around us a better place through our work and our actions.

Team Culture

At Syner-G, our culture is a beacon of inspiration, where innovation thrives at the intersection of creativity and science. Our team members are the heartbeat of our mission to revolutionize patient care and enhance human health. In an environment where every task is completed with purpose, we inspire each other to push the boundaries of what’s possible in the pharmaceutical industry. Our commitment to fostering a supportive and dynamic workplace encourages continuous learning, professional growth, and a genuine balance between work and well-being. At Syner-G, we’re not just transforming the industry; we’re inspiring greatness in every employee, driving them to make a meaningful impact and grow alongside the innovators shaping the future of healthcare.

Our History

2007

Founded as Syner-G Pharma Consulting by Prabu Nambiar and Binesh Prabhakar

2012

10+ Active Clients

2015

• 30+ Active Clients
• 50+ Successful Regulatory Filings

2016

• Introduced CMC 360 Model

• Started India Operations

2017

• 75+ Active Clients
• 150+ Successful Regulatory Filings

2018

Recognized as One of the “Top 10 Drug Development and Consulting Services Companies” (Pharma Tech Outlook)

2019

Innovative Regulatory CMC Onshore / Offshore Delivery Model Established (Functional Outsourcing)

2020

Equity Investment from Riverside Partners LLC

2021

PAN India Operations; Expansion of Functional Outsourcing Partnerships

2021

• 150+ FTEs
• 250+ Succesful Regulatory Filings
• Syner-G acquires IMPACT Pharmaceutical Services Pharmaceuticals
• 45+ FTEs in Medical Writing, Regulatory Strategy, and Regulatory Submissions

2022

• CMC360 development model embedded at multiple small biotechs
• India-based Person-In-Plant services operating at scale

2023

• 230+ FTEs
• Syner-G acquires RMC Pharmaceutical Solutions
• 30+ FTEs in CMC Biologics

2024

Named a Best Places to Work by Biospace

Offshore Capabilities

Syner-G has a purpose-built team in India with experts that match our leading capabilities in the US. Our India-based team is composed of scientists with PhDs, M. Pharm, MS Chemistry, and MBAs delivering CMC Development, Regulatory, and QA services. Our teams routinely work as a global integrated team on behalf of our clients to advance their development and commercial programs with a range of activities including Person-in-Plant, QA Audits, CDMO selection and oversight, training, and life-cycle maintenance. Having an expert team on the ground in India is not only cost-effective but critical in ensuring development timelines are met.